Unresectable Locally Advanced Pancreatic Cancer: A Multimodal Treatment Using Neoadjuvant Chemoradiotherapy (Gemcitabine Plus Stereotactic Radiosurgery) and Subsequent Surgical Exploration

@article{Polistina2010UnresectableLA,
  title={Unresectable Locally Advanced Pancreatic Cancer: A Multimodal Treatment Using Neoadjuvant Chemoradiotherapy (Gemcitabine Plus Stereotactic Radiosurgery) and Subsequent Surgical Exploration},
  author={F Polistina and Giorgio Costantin and PhD Franco Casamassima and Paolo Francescon and Rosabianca Guglielmi and Gino Panizzoni and Antonio Febbraro and PhD Giovanni Ambrosino},
  journal={Annals of Surgical Oncology},
  year={2010},
  volume={17},
  pages={2092-2101}
}
Pancreatic cancer accounts for approximately 3% of cancer deaths in Europe. Locally advanced pancreatic cancer (LAPC) involves vascular structures, and resectability is low, with a median survival time of 6 to 11 months. We conducted a prospective, nonrandomized study of patients with LAPC to assess the effect of stereotactic body radiotherapy (SBRT) on local response, pain control, and quality of life (QOL). Twenty-three patients with histologically confirmed LAPC underwent SBRT. Radiotherapy… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 54 CITATIONS

FILTER CITATIONS BY YEAR

2010
2019

CITATION STATISTICS

  • 2 Highly Influenced Citations

  • Averaged 8 Citations per year over the last 3 years

References

Publications referenced by this paper.
SHOWING 1-10 OF 33 REFERENCES

Similar Papers

Loading similar papers…